Global /Taiwan /Healthcare /Biotechnology /4195

Genomics BioSci & Tech. Co.,Ltd.

4195

• TPEX: 4195 • Delayed

29.50TWD -0.8%

0.9324 USD

As of 20 June 2026, Genomics BioSci & Tech. Co.,Ltd. has a market cap of $68.16M USD, ranking #28310 globally and #1650 in Taiwan. It ranks #2561 in the Healthcare sector, and #497 in the Biotechnology industry.

Global Rank

28310

Country Rank

1650

Sector Rank

2561

Industry Rank

497

Key Stats

Market Cap

$68.16MUSD

2.16B TWD

Enterprise Value

$84.78MUSD

2.68B TWD

Revenue (TTM)

$22.4MUSD

708.38M TWD

EBITDA (TTM)

-$655.1KUSD

-20.73M TWD

Net Income (TTM)

-$1.25MUSD

-39.43M TWD

EBITDA Margin

-2.9%

Profit Margin

-5.6%

PS Ratio

3.0

PB Ratio

3.7

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Biotechnology

CEO

Rita Wu open_in_new

Founded

2001

Website

genomics.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	0.7%	12%	19%	14%	14%	63%	48%	87%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	4195 基龍米克斯生物科技股份有限公司 ISIN: TW0004195003 Shares Out.: Shares Outstanding: 72.448M¹ TV: TradingView: TPEX: 4195 SA: Stock Analysis: TPEX: 4195 YF: Yahoo Finance: 4195.TWO GF: Google Finance: TPEX: 4195 BA: Barron's: 4195 MS: Morningstar: ROCO: 4195	29.50 TWD	TV: TradingView: TPEX: 4195 SA: Stock Analysis: TPEX: 4195 YF: Yahoo Finance: 4195.TWO GF: Google Finance: TPEX: 4195 BA: Barron's: 4195 MS: Morningstar: ROCO: 4195

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Genomics BioSci & Tech. Co.,Ltd.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan.

Similar Companies

Industry: Biotechnology (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Caliway Biopharmaceuticals Co., Ltd. TWSE: 6919	$5.46B 172.76B TWD 8K%	-	Taiwan
Pell Bio-Med Technology Co., Ltd. TWSE: 6949	$1.61B 50.93B TWD 2K%	-	Taiwan
Lin BioScience, Inc. TPEX: 6696	$1.08B 34.04B TWD 1K%	-	Taiwan
HanchorBio Inc. TWSE: 7827	$726.25M 22.97B TWD 966%	-	Taiwan
HanchorBio Inc. TPEX: 7827	$600.25M 18.98B TWD 781%	-	Taiwan
Locus Cell Co., Ltd. TPEX: 06891	$571.26M 18.06B TWD 738%	-	Taiwan

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 268K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 235K%	19.0	United States
argenx SE EBR: ARGX	$47.43B 41.39B EUR 69K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.23B 68.19T KRW 65K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.27B 60.27B AUD 62K%	29.3	Australia
Lonza Group AG SIX: LONN	$41.88B 33.71B CHF 61K%	37.2	Switzerland

chevron_leftBack